iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Get Free Report)’s share price reached a new 52-week high on Wednesday . The stock traded as high as $92.42 and last traded at $92.42, with a volume of 11949 shares changing hands. The stock had previously closed at $91.19.
iShares U.S. Pharmaceuticals ETF Stock Down 0.7%
The firm has a market capitalization of $993.60 million, a price-to-earnings ratio of 17.75 and a beta of 0.49. The business’s fifty day moving average is $87.49 and its 200 day moving average is $86.66.
Institutional Trading of iShares U.S. Pharmaceuticals ETF
A number of institutional investors have recently modified their holdings of the company. Royal Bank of Canada boosted its position in iShares U.S. Pharmaceuticals ETF by 0.3% during the 1st quarter. Royal Bank of Canada now owns 101,984 shares of the company’s stock worth $7,197,000 after acquiring an additional 325 shares during the last quarter. Goldman Sachs Group Inc. lifted its position in shares of iShares U.S. Pharmaceuticals ETF by 4.8% in the first quarter. Goldman Sachs Group Inc. now owns 104,815 shares of the company’s stock worth $7,396,000 after purchasing an additional 4,815 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in iShares U.S. Pharmaceuticals ETF by 781.6% during the second quarter. JPMorgan Chase & Co. now owns 110,936 shares of the company’s stock worth $7,271,000 after purchasing an additional 98,352 shares during the last quarter. Raymond James Financial Inc. boosted its holdings in iShares U.S. Pharmaceuticals ETF by 3.2% during the second quarter. Raymond James Financial Inc. now owns 63,564 shares of the company’s stock worth $4,166,000 after purchasing an additional 1,955 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its position in iShares U.S. Pharmaceuticals ETF by 491.9% in the second quarter. Ameriprise Financial Inc. now owns 23,658 shares of the company’s stock valued at $1,550,000 after purchasing an additional 19,661 shares in the last quarter.
iShares U.S. Pharmaceuticals ETF Company Profile
iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.
See Also
- Five stocks we like better than iShares U.S. Pharmaceuticals ETF
- Marvell’s Pullback May Be the Setup Bulls Were Waiting For
- Flight Path to Profits: American Airlines Bets on SpaceX
- Wall Street Is Starting to Talk About Tesla’s Endgame
- Meta’s Manus Mess: Why China Blocked the Deal and What It Means
Receive News & Ratings for iShares U.S. Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
